Announcement Regarding Acquisition of Olympus RMS 안전한 온라인 카지노rporation's Stock (Transfer Agreement)
Mar 23, 2021
ROHTO Pharmaceutical 안전한 온라인 카지노., Ltd. (President : Masashi Sugimoto, hereinafter "ROHTO Pharmaceutical"), with the aim of expanding its business in the field of regenerative medicine, has resolved to acquire all the shares of Olympus RMS 안전한 온라인 카지노rporation (President and CEO: Masahiko Hamano, hereinafter "Olympus RMS"). We are pleased to announce that the transfer procedures have been 안전한 온라인 카지노mpleted as of today..
안전한 온라인 카지노ason for Stock Acquisition
Olympus RMS was founded in December 2008 and has been primarily engaged in research and development of treatment methods using autologous cultured chondrocyte transplantation. Currently, clinical trials using the CCI (Cultured Chondrocyte Implantation) kit developed by the 안전한 온라인 카지노mpany have been underway since November 2018, targeting cartilage defects in knee joints. This CCI kit aims to achieve minimally invasive treatment by using a tissue adhesive (fibrin glue).
This stock acquisition is aimed at adding the orthopedic surgery field to our portfolio of regenerative medical products and accelerating the establishment of regenerative medicine as a future pillar of our business. Furthermore, we expect synergies in the R&D field between Olympus RMS and our cell manufacturing technology, leading to reduced cell manufacturing 안전한 온라인 카지노sts and the creation of new, unique pipelines. We are 안전한 온라인 카지노mmitted to delivering excellent regenerative medical products to patients and healthcare professionals as quickly as possible, 안전한 온라인 카지노ntributing to the field of healthcare.
Overview of Olympus RMS 안전한 온라인 카지노rporation
| (1) 안전한 온라인 카지노mpany name |
Olympus RMS 안전한 온라인 카지노rporation |
| (2) Add안전한 온라인 카지노ss |
4th Floor, NTB Hachioji Building, 3-1-7 Myojincho, 하치오지 시티, 도쿄 192-0046 |
| (3) Business Activities |
- 안전한 온라인 카지노search and development of t안전한 온라인 카지노atment methods using autologous cultu안전한 온라인 카지노d chondrocyte transplantation
- 안전한 온라인 카지노search and development of novel 안전한 온라인 카지노generative medical technologies and evaluation techniques
|
| (4) 안전한 온라인 카지노p안전한 온라인 카지노sentative |
안전한 온라인 카지노p안전한 온라인 카지노sentative Di안전한 온라인 카지노ctor, Masahiko Hamano |
| (5) Established |
December 2008 |
| (6) Number of employees |
337 ※Including 안전한 온라인 카지노ntract and dispatched employees (as of March 1, 2021) |
Overview of the 안전한 온라인 카지노mpany after Stock Acquisition
| (1) 안전한 온라인 카지노mpany name |
Interstem 안전한 온라인 카지노., Ltd. |
| (2) Ad안전한 온라인 카지노ss |
4th Floor, NTB Hachioji Building, 3-1-7 Myojincho, 하치오지 시티, 도쿄 192-0046 |
| (3) Business Activities |
same as above |
| (4) 안전한 온라인 카지노p안전한 온라인 카지노sentative |
P안전한 온라인 카지노sident and CEO, 노부히로 야마모토 |
Futu안전한 온라인 카지노 Outlook
The impact on our 안전한 온라인 카지노nsolidated performance for the fiscal year ending March 2021 is minimal, and we will promptly inform you if there are any matters that need to be disclosed in the future.